Quidel | QDEL - Equity Capital And Reserves


Quidel reported $1.85B in Equity Capital and Reserves for its fiscal quarter ending in March of 2026.





Equity Capital And Reserves Change Date
Abbott USD 52.06B 69M Mar/2026
Agilent USD 7.12B 214M Mar/2026
Becton, Dickinson and Co. USD 24.42B 283M Jun/2026
Bruker USD 2.5B 46.3M Mar/2026
Cerus USD 64.22M 2.76M Dec/2025
Charles River Laboratories USD 2.84B 59.06M Jun/2026
Danaher USD 52.58B 368M Jun/2026
Haemonetics USD 837.1M 40.78M Jun/2026
Illumina USD 2.84B 162M Jun/2026
IQVIA Holdings USD 6.17B 50M Jun/2026
Merit Medical Systems USD 1.68B 53.08M Jun/2026
Mettler Toledo International USD 12.82M 54.71M Jun/2026
Myriad Genetics USD 303.9M 33.5M Jun/2026
Neogen USD 2.09B 9.5M Mar/2026
OraSure Technologies USD 313.32M 27.5M Mar/2026
Pacific Biosciences Of California USD -33.21M 35.58M Jun/2026
Quidel USD 1.85B 69.1M Mar/2026
Revvity USD 7.18B 67.62M Mar/2026
STAAR Surgical USD 352.37M 8.18M Mar/2026
Thermo Fisher Scientific USD 51.93B 1.6B Mar/2026
Waters USD 15.29B 12.73B Mar/2026